ASArgyrios Stampas

Argyrios Stampas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Argyrios Stampas has a total of 110 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Editorial Comment

    by Argy Stampas, Rachel High

  • Urinary Biomarkers for Screening High‐Risk Urodynamic Phenotypes in Early Spinal Cord Injury: A Pilot Study

    by Catherine Forster, Danira Garcia Gutierrez, Rose Khavari, Bich Na Choi, Suzanne Groah, Argy Stampas

    Introduction: Neurogenic bladder (NB) following spinal cord injury (SCI) is associated with significant morbidity, yet early characterization remains limited. Urodynamic studies (UDS), the gold standard for evaluation, are not routinely performed early after SCI due to unclear guidelines and limited access. We evaluated whether urinary biomarkers could identify high‐risk bladder phenotypes early after SCI. Materials and Methods: We conducted a prospective cohort study of 45 individuals with acute SCI (≤ 6 weeks post‐injury), including 35 catheter‐dependent participants who underwent UDS and 10 spontaneously voiding controls without UDS. Urine samples were analyzed by nine biomarkers using ELISA. High‐risk bladder was defined as detrusor overactivity (DO), detrusor sphincter dyssynergia (DSD), elevated detrusor pressure (≥ 40 cm H 2 O), or low compliance (< 15 mL/cm H 2 O). Biomarker performance was assessed using penalized regression with bootstrap‐corrected metrics. Results: Individual biomarkers demonstrated moderate discrimination, including NGAL for DO (AUC 0.75), NGAL for DSD (AUC 0.84), and RANTES/CCL5 for elevated detrusor pressure (AUC 0.73). A multivariable panel improved detection of high‐risk bladder (AUC 0.73, 95% CI 0.59–0.89). At a sensitivity‐optimized threshold, the model achieved sensitivity 0.94, negative predictive value 0.92, and negative likelihood ratio 0.16. Model discrimination was preserved after accounting for urinary inflammation, although individual biomarkers showed differential sensitivity. Conclusions: Urinary biomarkers show promise as a noninvasive approach to identify individuals with early SCI at risk for adverse urodynamic findings. This approach may support earlier risk stratification and targeted use of UDS during inpatient rehabilitation. Larger studies are needed to validate these findings and define their clinical role. Trial Registration: This study was conducted as part of a registered clinical trial ( ClinicalTrials.gov Identifier: NCT04350359).

  • Crossroads in Spinal Cord Injury Treatment

    by Radha Korupolu, Dennis Bourbeau, Anne M Bryden, Rory Cooper, James Guest, Candace Tefertiller, Lisa Wenzel, Susan Robinson-Whelen, Argy Stampas

    The Crossroads in Spinal Cord Injury Treatment: Present and Future conference, held in Houston, Texas in January 2026, brought together a multidisciplinary group of clinicians, researchers, engineers, and individuals living with spinal cord injury (SCI) to examine future directions of SCI care and research. This narrative summarizes themes, emphasizing the need to align scientific innovation with implementation in clinical settings. The conference was structured around priorities from individuals with SCI, including upper limb function, bowel and bladder management, pain, independence, and psychosocial well-being. Across sessions, speakers highlighted gaps in translation into practice. Major topics included challenges in clinical trial design, advocacy efforts to address policy barriers and inequities, and emerging approaches in neuromodulation, surgical reconstruction, and rehabilitation technologies. Additional focus areas included under-researched domains such as neurogenic bowel and bladder, disparities in care for women, and the clinical impact of autonomic dysfunction. Psychosocial health, pain, mental health, and sexuality were emphasized as central to quality of life. Engineering discussions underscored interdisciplinary collaboration and user-centered design. Overall, the conference highlighted that the field of SCI is at a critical crossroads, where progress will depend on effective implementation, equitable access, and integration of lived experience into research and clinical care.

  • Open Access

    Early urodynamic studies after spinal cord injury: time to reconsider clinical practice

    by Argyrios Stampas, Rose Khavari, Danira Gutierrez, Hunter Hasley, Suzanne Groah

    Study Design: Secondary analysis of a prospective clinical trial. Objectives: To evaluate whether urodynamic studies (UDS) performed in early spinal cord injury (SCI) identify actionable bladder dysfunction and influence clinical decision-making. Setting: Acute inpatient rehabilitation facility in the United States Methods: People with SCI admitted within 6 weeks of injury were included. Individuals who consented underwent UDS (UDS group), while those who declined participation served as the comparison (no UDS group). UDS measures included detrusor overactivity, detrusor sphincter dyssynergia, low compliance (≤ 15 mL/cm H2O), cystometric capacity (< 300 mL), and detrusor pressure ≥ 40 cm H2O. High-risk bladder was defined by these abnormalities. Multivariable Firth logistic regression evaluated associations with overactive bladder (OAB) medication use and urinary tract infection (UTI). Results: A total of 149 individuals were included (70 no UDS, 79 UDS). Urodynamic abnormalities were identified in 57%. OAB medication use was higher in the UDS group (16% vs 9%). High-risk bladder was associated with OAB medication use (24% vs 6%; OR 4.33, 95% CI, 1.01 to 18.48) and remained significant after adjustment for discharge voiding method (OR 4.58, 95% CI, 1.07 to 19.72). Individuals with high-risk findings were more likely to receive OAB medications than those without UDS (24% vs 9%; OR 3.31, 95% CI, 1.16 to 9.42). UDS exposure was not associated with UTI (OR 1.51, 95% CI, 0.76 to 2.98). Conclusions: UDS in early SCI identifies clinically actionable bladder dysfunction and is associated with changes in bladder management. These findings support consideration of urodynamic evaluation during inpatient rehabilitation.

  • Open Access

    Location-, intensity-, and frequency-optimized epidural stimulation restores hand function after complete spinal cord injury

    by Jeonghoon Oh, Alexander G. Steele, Michelle Scheffler, Catherine Martin, Jony Sheynin, Valerie A. Dietz, Alejandra Valdivia-Padilla, Jenny Dinh, Argyrios Stampas, Radha Korupolu, et al.

    Cervical spinal cord injury (SCI) causes profound and persistent loss of hand function, and effective neuromodulation strategies remain limited. We report the first-in-human implantation of a 32-contact cervical epidural paddle array in two individuals with severe chronic SCI. Individualized motor pool recruitment maps, derived from systematic bipolar and multipolar configurations, enabled person-specific stimulation parameters. Optimized stimulation restored volitional hand opening, closing and coordinated upper-limb movements that were previously unattainable. This approach achieved a >91% success rate in complex reach-grasp-lift-release sequences, supported by substantial gains in range of motion, grip, and pinch strength. Electrophysiological and kinematic analyses demonstrated parameter-dependent, selective recruitment of flexor and extensor motor pools. Personalized stimulation programs integrated with goal-directed activities enabled functional hand use in home and community settings, sustained over several months of continued autonomous use. These findings establish a mechanistically grounded and translational framework for restoring upper-limb function after chronic severe SCI.


  • Predicting Complete Injury in Spinal Cord Injury Patients by Applying Machine Learning Methods to Heart Rate Variability

    by Azharmadani Syed, Bowen Yang, Argyrios Stampas, Tianfu Wu

    Objective: The aim of the study was to develop a model using machine learning algorithms for diagnosing complete and incomplete injury from heart rate variation (HRV) parameters and other easily obtained demographics. Design: Random Forest, Decision Tree, KNN Classifier, Gradient Boost, Bagging Classifier, Support Vector Machine, Voting Classifier, XGB Classifier, MLP Classifier and feedforward neural networks were trained on 296 sets of patient data including 11 HRV parameters. Feature selection methods were used to improve models and identify parameters with high contribution to model predictions. Results: The feature selected MLPClassifier achieved an accuracy of 85.33%, with an AUC of 0.8590 while the neural network model had an accuracy of 86.67% with an AUC of 0.9608. Location of spinal injury, age, mean heart rate and mean R-R interval were the greatest contributors to the machine learning models. Conclusions: This study demonstrated that machine learning algorithms trained on HRV data could be an invaluable tool for diagnosing and monitoring people with SCI and overall improving their quality of life.

  • Open Access

    Advancements in Understanding Spasticity: A Neuromusculoskeletal Modeling Perspective

    by Mohammad S. Shourijeh, Argyrios Stampas, Shuo-Hsiu Chang, Radha Korupolu, Gerard E. Francisco

    Spasticity, a complex consequence of upper motor neuron lesions, poses challenges for clinical assessment due to its neural and mechanical origins. Traditional scales like the Modified Ashworth and Tardieu Scales provide subjective, context-limited insights, often missing spasticity’s dynamic nature. Neuromusculoskeletal (NMS) modeling offers objective, quantitative insights by integrating patient-specific muscle–tendon properties, reflex dynamics, and multi-joint biomechanics. This scoping review examines advancements in spasticity modeling, comparing mechanical, neurological, and integrated approaches, and their applications in conditions like cerebral palsy and stroke. We highlight barriers to clinical translation, including computational demands and regulatory challenges, and propose future directions, such as real-time simulation and machine learning integration, to enhance personalized assessment and treatment.


  • Open Access

    Advancements in Understanding Spasticity: A Neuromusculoskeletal Modeling Perspective

    by Mohammad S. Shourijeh, Argyrios Stampas, Shuo-Hsiu Chang, Radha Korupolu, Gerard E. Francisco

    Spasticity, a complex consequence of upper motor neuron lesions, poses challenges for clinical assessment due to its neural and mechanical origins. Traditional scales like the Modified Ashworth and Tardieu Scales provide subjective, context-limited insights, often missing spasticity’s dynamic nature. Neuromusculoskeletal (NMS) modeling offers objective, quantitative insights by integrating patient-specific muscle-tendon properties, reflex dynamics, and multi-joint biomechanics. This scoping review examines advancements in spasticity modeling, comparing mechanical, neurological, and integrated approaches, and their applications in conditions like cerebral palsy and stroke. We highlight barriers to clinical translation, including computational demands and regulatory challenges, and propose future directions, such as real-time simulation and machine learning integration, to enhance personalized assessment and treatment.


  • Optimizing the Injection Schema for Higher Doses of OnabotulinumtoxinA (BTX‐A) in the Office Setting: A Randomized Prospective Trial for Patients With Neurogenic Lower Urinary Tract Dysfunction and Idiopathic Overactive Bladder

    by Annie Chen, Julie Stewart, Ricardo R. Gonzalez, Argyrios Stampas, Kathleen Kobashi, Rose Khavari

    Background: OnabotulinumtoxinA (BTX‐A) decreases urge urinary incontinence (UUI) and improves quality of life for patients with idiopathic overactive bladder (IOAB) and neurogenic lower urinary tract dysfunction (NLUTD). Limited research exists optimizing injection techniques for higher doses (200‐ or 300‐units) of BTX‐A in the clinic setting. Optimization with less injections could improve satisfaction and willingness to repeat injections while maintaining effectiveness. Methods: This is a prospective, single‐blinded, parallel randomized controlled trial of patients undergoing higher doses of BTX‐A for treatment of refractory IOAB or NLUTD in the office setting. Patients were randomized to either 5‐ or 20‐injections. The primary outcome was patients' willingness to repeat the procedure. Secondary outcomes included pain, symptomatology, and adverse events (AEs) assessments. Results: For N = 78 participants ( N = 39 per arm), no difference was seen in patients' willingness to repeat the procedure between the 5‐ or 20‐injection groups before and after injection (Mean difference = 0.18, p = 0.57) or at 6–8 week follow‐up (Mean difference = 0.06, p = 0.83). There was a significant increase in immediate post‐procedural pain after 20 ( M = 3.39, SD 3.01) compared to five injections ( M = 0.57, SD = 2.07) (Mean difference = 2.83, p > 0.00002). N = 55/78 (71%) completed follow‐up. N = 16 experienced AEs ( N = 8/26 for 5‐injections, N = 7/29 for 20‐injections). Conclusions: Despite a significant increase in pain for patients with NLUTD and IOAB receiving 20 injections compared to 5, patients in both groups were equally willing to repeat BTX‐A injections. There were no significant differences in AEs or secondary outcomes. This suggests decreasing the number of injections from 20 to 5 will improve pain scores when higher doses of BTX‐A are used in the office setting with affecting efficacy. Clinical Trial Number: NCT06059066.


  • Spinal Cord Lower Urinary Tract Control in Humans

    by Betsy H. Salazar, Charles M. Mazeaud, Kristopher A. Hoffman, Argyrios Stampas, Rose Khavari

    Background and Objective: Although there have been significant advancements in functional magnetic resonance imaging (fMRI) studies that have enhanced our understanding of brain control over bladder function in humans, a notable gap still exists in exploring spinal cord involvement in real‐time. The objective of this study was to develop and validate an fMRI protocol to assess innate spinal cord activity in humans within regions associated with bladder function.Methods: Twenty healthy adult participants 9 men, 11 women underwent functional magnetic resonance imaging (fMRI) of the spinal cord during implementation of a natural bladder filling protocol and simulated bulbocavernosus reflex (sBCR). Anatomical images were obtained, followed by resting‐state and task‐based fMRI assessments during both full and empty bladder states. Functional spinal neuroimaging data were analyzed using a custom pipeline comprised of Spinal Cord Toolbox, FSL, and MATLAB scripts for preprocessing and analysis.Key Findings and Limitations: Our preliminary findings revealed activation in 15 participants (7 men, 8 women), exhibiting diverse patterns of activity across the T10‐S5 neuronal segments during task‐fMRI sessions conducted with both empty and full bladder conditions during sBCR. The identified activated regions included sympathetic (T10‐L2), parasympathetic (S2–S4), and somatic nuclei (S2–S4), previously implicated in facilitating lower urinary tract (LUT) control. Notably, our preliminary findings suggest that sex differences may influence these activation patterns, though further investigation and second‐level analysis are warranted to confirm this observation.Conclusions: Although preliminary, our findings demonstrate, for the first time, the efficacy of our fMRI protocol in detecting task‐induced activity in the lumbosacral spinal cord, underscoring our capability to precisely target specific regions responsible for regulating LUT function.